RGLS
Regulus Therapeutics
RGLS
RGLS
Delisted
RGLS was delisted on the 24th of June, 2025.
41 hedge funds and large institutions have $15.9M invested in Regulus Therapeutics in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 11 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
27% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 11
33% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 9
Holders
41
Holding in Top 10
1
Calls
$373K
Puts
$216K
Top Buyers
| 1 | +$649K | |
| 2 | +$130K | |
| 3 | +$56.3K | |
| 4 |
Morgan Stanley
New York
|
+$44.8K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$26.8K |
Top Sellers
| 1 | -$248K | |
| 2 | -$166K | |
| 3 | -$163K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$98.4K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$75K |